Request Virtual Presentation
Explore the below topics with us during a Virtual Presentation of our resources, capabilities and solutions tailored to support your success.
A tougher regulatory environment, stronger competition and uncertain economic climate has the industry refocus to build stronger, bigger pipelines. Slight increases in the number of drugs in development in 2009 compared to previous years shows companies are investing more heavily in their Research & Development efforts. Lately, there has seen a significant growth in the number of start ups and small biotechs and pharmaceuticals with one or two products in development. Larger pharma companies, on the other hand, have focused on their core products and M&A driven pipeline growth.
But just how much should you invest in your Research & Development department? What is the right portfolio mix? And what should your company's development strategy be for the next years?
The Research and Advisory Services team can answer these critical questions. We provide you with resources to help you build adequate Research & Development functions that produce steady pipelines, innovation and growth.
Research and Advisory Services analysts have supported many clients on initiatives aimed to optimize their R&D efforts:
Explore these and other topics with us during a Virtual Presentation of our resources, capabilities and solutions tailored to support your success.
Benefits of a Partnership with Research and Advisory Services
President and CEO